(2R)-2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2-methyl-6-heptenoic acid(CAS: 288617-77-6)

This compound is subject to the REACH regulations in the European Union, requiring suppliers to register the substance if the annual production or import volume exceeds one tonne. In the USA, it is also regulated by the EPA, and for pharmaceutical applications, FDA may require specific safety evaluations. Additionally, it should be handled in accordance with the Globally Harmonized System (GHS) for classification and labeling of chemicals.

Alternative reagents for synthesis include related cyclic peptides and fluorenylmethoxycarbonyl (Fmoc) protected amino acids. Isomers such as the (2S)-isomer can be used as alternatives depending on the specific application. Other common substitutes include unprotected amino acids or modified versions of the compound.

The market trend for this compound is driven by its use in drug development, particularly in the synthesis of novel peptides and proteins. Research is focusing on its potential applications in cancer therapy and as a building block for medicinal chemistry. Prices and supply are influenced by the increasing demand from pharmaceutical companies and academic research institutions.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method, but care must be taken to ensure that emissions comply with local environmental regulations. Environmental protection measures should include proper containment to prevent leaks and spills, and the waste should be neutralized before disposal if necessary.